Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-03

Study Completion Date

2022-12-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient.

Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity.

The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management.

This new organisation is part of the policy of continuous improvement of the quality and safety of care

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medication Reconciliation at Discharge: Impact on Patient's Care

NCT03029052

Medication Reconciliation

COMPLETED NA

Communication Between Hospital and Community Pharmacists: Impact on Drug Management at Discharge

NCT02006797

Treatment Error

UNKNOWN NA

Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly

NCT02906657

Adverse Drug Event

COMPLETED NA

Study to Assess the Impact of Medication Reconciliation at Hospital Admission on Healthcare Outcomes

NCT03654963

Safety Issues

COMPLETED NA

Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital

NCT00296426

Medication Reconciliation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospitalized Patient

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Drug reconciliation

Drug reconciliation and transmission to pharmacist

Group Type EXPERIMENTAL

Drug reconciliation

Intervention Type OTHER

Drug reconciliation information transmission to pharmacist interview with the patient

standard

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Drug reconciliation

Drug reconciliation information transmission to pharmacist interview with the patient

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hospitalized patient
* Patient with a drug treatment with a particular mode of supply
* Paediatric patient or an adult patient.
* First inpatient stay over the inclusion period from late 2021 to late 2022